LH - Laboratory Corp of America Holdings - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - LH (920148)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
29 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-11-08
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale$232.67-1,1166,687-14%-$259,660
2022-09-26
LHEisenberg Glenn ACFO, EVPS - Sale$210.62-25,00027,158-48%-$5,265,576
2022-09-07
LHCaveney Brian JEVP, Pres of DiagnosticsP - Purchase$231.20+4414,2820%+$10,251
D
2022-08-03
LHEisenberg Glenn ACFO, EVPS - Sale+OE$253.94-32,10052,158-38%-$8,151,449
D
2022-08-01
LHWilkinson Peter JSVP, Chief Accounting OfficerS - Sale+OE$258.40-2,5761,914-57%-$665,635
2022-06-07
LHCaveney Brian JEVP, Pres of DiagnosticsP - Purchase$242.19+4214,1720%+$10,174
2022-03-29
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale$277.11-2,3566,605-26%-$652,871
2022-03-29
LHVan Der Vaart Sandra DEVP, GCS - Sale$277.11-2,4495,287-32%-$678,642
2022-03-25
LHWilliams R SandersDirS - Sale$272.98-5726,431-8%-$156,145
2022-03-10
LHSummy Amy B.EVP, CMOS - Sale$262.21-249250-50%-$65,290
2022-02-16
LHNeupert Peter MDirP - Purchase$263.66+3,50010,254+52%+$922,815
2022-02-15
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale$273.98-2076,605-3%-$56,714
2022-02-15
LHVan Der Vaart Sandra DEVP, GCS - Sale$273.98-2075,287-4%-$56,714
D
2022-02-07
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale+OE$277.38-2046,605-3%-$56,586
D
2022-02-07
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$277.38-2185,287-4%-$60,469
D
2022-02-03
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale+OE$271.81-1616,401-2%-$43,761
D
2022-02-03
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$271.81-1725,287-3%-$46,751
2021-12-15
LHGilliland Dwight GaryDirS - Sale$302.26-5006,252-7%-$151,128
D
2021-09-15
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$296.78-4,5005,265-46%-$1,335,510
D
2021-06-07
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$266.56-4,5005,237-46%-$1,199,520
2021-05-06
LHKirchgraber Paul RCEO, Covance Drug DevelopmentS - Sale$276.55-2,5007,844-24%-$691,375
D
2021-05-03
LHBelingard Jean-LucDirS - Sale+OE$269.16-2,60015,569-14%-$699,803
2021-03-30
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale$251.88-6675,006-12%-$168,004
2021-03-30
LHVan Der Vaart Sandra DEVP, GCS - Sale$251.88-8125,237-13%-$204,527
D
2021-02-18
LHWilkinson Peter JSVP, Chief Accounting OfficerS - Sale+OE$241.52-2,317976-70%-$559,589
D
2021-02-16
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$236.55-2084,426-4%-$49,202
D
2021-02-16
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale+OE$237.06-1884,339-4%-$44,567
D
2021-02-05
LHVan Der Vaart Sandra DEVP, GCS - Sale+OE$225.85-1094,219-3%-$24,618
D
2021-02-05
LHSchroeder Mark SEVP, Pres-Diagnostics LabS - Sale+OE$225.85-2034,152-5%-$45,848

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top